Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Wilkinson

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|August 29, 2024
The Prognostic and Predictive Utility of CDX2 in Colorectal CancerWei Yen Chan, Wei Chua, Kate Wilkinson, et al.
Journal of Patient-Reported Outcomes|May 7, 2020
Psychometric evaluation of the Chinese version of the Toronto Hospital Alertness TestSha Li, Daniel Yee Tak Fong, Janet Yuen Ha Wong, et al.
General Hospital Psychiatry|June 16, 2023
Randomized trial of personalized psychological feedback from a longitudinal online survey and simultaneous evaluation of randomized stepped wedge availability of in-person peer support for hospital staff during the COVID-19 pandemicRobert G Maunder, Alex Kiss, Natalie Heeney, et al.
Drugs & Aging|October 23, 2025
Inclusion of Older Adults in Early-Phase Cancer Clinical Trials: Safety, Efficacy and a Way ForwardJessie Nguyen, Nicolò Matteo Luca Battisti, Danielle Ní Chróinín, et al.
Cancers|June 19, 2024
Microsatellite Instability Testing and Prognostic Implications in Colorectal CancerVincent Ho, Liping Chung, Kate Wilkinson, et al.
Cancers|May 4, 2026
Measuring What Matters: RECIST Response Does Not Predict HRQoL in Early-Phase Clinical TrialsJessie Nguyen, Udit Nindra, Joanne Tang, et al.
Plos One|October 5, 2023
Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian populationUdit Nindra, Abhijit Pal, Vivienne Lea, et al.
JNCI Cancer Spectrum|November 10, 2025
Prospective assessment of health-related quality of life in early phase oncology clinical trials: PEARLERUdit Nindra, Joanne Tang, Jun Hee Hong, et al.
JCO Oncology Practice|November 3, 2025
Assessing Patient-Reported Financial, Social, and Time Toxicity in Early-Phase Cancer Clinical Trials in Australia Through a Prospective Multicenter Nonrandomized Cohort StudyUdit Nindra, Joanne Tang, Jun Hee Hong, et al.
Cancer|January 31, 2023
A phase 1 dose-escalation study of the poly(ADP-ribose) polymerase inhibitor senaparib in Australian patients with advanced solid tumorsBo Gao, Mark Voskoboynik, Adam Cooper, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|August 29, 2024
The Prognostic and Predictive Utility of CDX2 in Colorectal CancerWei Yen Chan, Wei Chua, Kate Wilkinson, et al.
Journal of Patient-Reported Outcomes|May 7, 2020
Psychometric evaluation of the Chinese version of the Toronto Hospital Alertness TestSha Li, Daniel Yee Tak Fong, Janet Yuen Ha Wong, et al.
General Hospital Psychiatry|June 16, 2023
Randomized trial of personalized psychological feedback from a longitudinal online survey and simultaneous evaluation of randomized stepped wedge availability of in-person peer support for hospital staff during the COVID-19 pandemicRobert G Maunder, Alex Kiss, Natalie Heeney, et al.
Drugs & Aging|October 23, 2025
Inclusion of Older Adults in Early-Phase Cancer Clinical Trials: Safety, Efficacy and a Way ForwardJessie Nguyen, Nicolò Matteo Luca Battisti, Danielle Ní Chróinín, et al.
Cancers|June 19, 2024
Microsatellite Instability Testing and Prognostic Implications in Colorectal CancerVincent Ho, Liping Chung, Kate Wilkinson, et al.
Cancers|May 4, 2026
Measuring What Matters: RECIST Response Does Not Predict HRQoL in Early-Phase Clinical TrialsJessie Nguyen, Udit Nindra, Joanne Tang, et al.
Plos One|October 5, 2023
Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian populationUdit Nindra, Abhijit Pal, Vivienne Lea, et al.
JNCI Cancer Spectrum|November 10, 2025
Prospective assessment of health-related quality of life in early phase oncology clinical trials: PEARLERUdit Nindra, Joanne Tang, Jun Hee Hong, et al.
JCO Oncology Practice|November 3, 2025
Assessing Patient-Reported Financial, Social, and Time Toxicity in Early-Phase Cancer Clinical Trials in Australia Through a Prospective Multicenter Nonrandomized Cohort StudyUdit Nindra, Joanne Tang, Jun Hee Hong, et al.
Cancer|January 31, 2023
A phase 1 dose-escalation study of the poly(ADP-ribose) polymerase inhibitor senaparib in Australian patients with advanced solid tumorsBo Gao, Mark Voskoboynik, Adam Cooper, et al.
Pageof 4